Avac Event

Exploring Dapivirine Ring Results

In the first webinar in our post-CROI webinar series, Jared Baeten (MTN) and Zeda Rosenberg (IPM) spoke about the dapivirine ring trial results announced at the conference and fielded questions from webinar participants.

Download slides and audio from the webinar. A video version is available below.

Avac Event

PrEP and Women in the US: Update on the science, research and implementation

The US women and PrEP Working Group held a webinar on the state of the science and implementation of PrEP for women in the US. Slides are available below.

Avac Event

Long-Acting Injectables Antiretrovirals for Treatment and Prevention

Heard about a “tail” for long-acting injectables and want to know more? Interested in the timeline for when people with HIV might have injectable drug options for treatment? Wondering how people felt about getting an injection for PrEP? David Margolis (ViiV Healthcare) and Marty Markowitz (Aaron Diamond AIDS Research Center) spoke about long-acting injectable antiretrovirals for treatment and prevention.

Click for the slides and an audio recording. A link to the Flash animation is below.

At CROI, Margolis presented findings from the LATTE 2 trial, which tested a pair of long-acting injectables—cabotegravir (from ViiV Healthcare) and rilpivarine (from Janssen)—for HIV maintenance therapy, and Markowitz presented findings from the ÉCLAIR paste 2A study of cabotegravir in HIV-uninfected men.

And this webinar is part of our post-2016 CROI webinar series. Click for more information.

Avac Event

Harnessing Antibodies for HIV Prevention and Treatment

John Mascola of the NIH Vaccine Research Center spoke about harnessing antibodies for HIV prevention and treatment. The recording includes a question and answer period with webinar participants.

For further background, click here to view his CROI plenary session. And this webinar is part of our post-CROI 2016 webinar series. Click to learn more.

Avac Event

New York State 2016 HIV Cure Symposium: Connecting Research to Clinical Practice

This full day symposium will focus on progress being made in HIV cure research. It will highlight (1) research to improve stem cell transplants; (2) gene editing technology; (3) advances in immune modulators and latency reversing agents; (4) ethical concerns related to treatment interruption and patient risk; and (5) policy barriers.

At the conclusion of the symposium, participants should be able to:

  • Increase capacity of medical providers to discuss HIV cure research with patients
  • Summarize barriers of conducting HIV cure research in NY State and identify strategies to remove those barriers
  • Examine the place of HIV cure in the HIV care continuum

This symposium is restricted to New York State clinical providers, such as physicians, physician assistants, nurse practitioners, dentists, and pharmacists. Space will be limited!

Location:
New York University Kimmel Center
60 Washington Square South
New York, NY 10012

For More Information:
Contact Sainabou Jobe at [email protected] or 212-523-7284.

Avac Event

Community Perspectives from CROI 2016

Community Perspectives from CROI 2016 was the second in the 2016 WATCH webinar series that offers women living with HIV capacity building and training on HIV disease and treatment advocacy. During this webinar, participants received an overview of HIV science by several speakers, including:

  • Treatment Advocacy, Kate Borloglou, Community Advisory Board, The Well Project, Community Scientific Subcommittee, AIDS Clinical Trials Group (ACTG)
  • Pre-Exposure Prophylactics Research Updates from CROI 2016, Lisa Diane White, Deputy Director, SisterLove, Inc.
  • Ring, Injectables & Cure Research Updates from CROI 2016, Jessica Salzdewel, Program Coordinator, AVAC

This webinar series was moderated by Krista Martel, Executive Director, The Well Project.

Avac Event

PrEP in the Wild — A whirlwind tour of the who, what, where and how of PrEP use and provision outside of approval

In this webinar, presenters spoke about PrEP’s use and provision in countries that haven’t yet approved it or who are in the early days post approval. Among others, these presenters from Thailand, South Africa, England, Peru, Mexico and the United States took on the following questions and more:

  • Where is informal PrEP (“in the wild”) happening, among which populations?
  • What are the perspectives of patients and providers?
  • Are people following the full PrEP program (i.e. regular HIV and STI testing, medical monitoring, adherence support, sexual health counseling, other care)?
  • What do advocacy efforts look like in different countries?
  • What are the public’s perceptions of PrEP in different countries?
  • How can the “PrEP in the Wild” global survey help your work?

Watch a Flash animation version of the webinar.

Avac Event

Webinar: When the Evidence Is Not Enough – Hormonal Contraception and HIV

Uncertainty remains around hormonal contraception and its link to HIV acquisition. Given WHO’s recommendation that women should receive correct and full information to enable an informed choice regarding their method of contraception, the Health Communication Capacity Collaborative (HC3) developed the Strategic Communication Framework for Hormonal Contraceptive Methods and Potential HIV-Related Risks.

This strategic framework was designed to assist governments in developing a communication strategy and to guide the development of social and behavior change communication (SBCC) materials and activities focused on hormonal contraception and HIV. To date, Malawi’s and Swaziland’s Ministries of Health have adapted the framework to their country contexts and have subsequently developed SBCC materials on this topic.

This webinar presented the framework, speakers discussed the adaptation process in Malawi and Swaziland and provided the perspective of women living with HIV related to this issue.

Moderated by Nithya Mani, Division Chief, Implementation Support, Office of HIV/AIDS, USAID

Presenters:

  • WHO representative
  • Beth Mallalieu, HC3 HIV Program Officer
  • Triza Hara, Deputy Chief of Party, SSDI Malawi
  • Lindiwe Malaza, Family Planning Officer, Sexual and Reproductive
  • Health Programme, Ministry of Health, Swaziland
  • Woman Living with HIV/Advocate

Avac Event

HIV Vaccine Awareness Day 2016 Events

Global

  • Two live Twitter chats led by Youth Coalition Against AIDS (GYCA) to connect young people throughout Africa with HIV vaccine researchers and IAVI CEO to discuss HIV vaccine research issues.
  • “Know your rights” advocacy workshop, a one-hour online workshop led by ICW and facilitated by KAVI-ICR focusing on HIV vaccine R&D, to be attended by ICW women leaders around the world.

Kenya

  • Two-day HIV Research and Development Meeting led by WACI-Health for National Civil Society Leaders from the East and Southern African region; titled “Strengthening CSO Leadership in HIV Prevention Research & Development (R&D) in Eastern and Southern Africa (ESA) Region” the meeting aims to accelerate civil society action on investments and innovation in research on AIDS vaccines and other biomedical prevention.
  • Mobilizing event organized by KAVI-ICR, to include a boxing match, a procession led by a band, VCT provision, and speeches and updates on HIV and HIV research.

South Africa

  • Community event conducted by Aurum Institute with a football match between Aurum MMC clinic and the Clinical Research Centre, Edutainment, VCT, updates on HIV vaccine R&D, and distribution of IEC materials.

Thailand

  • HVAD outreach led by Armed Forces Research Institute of Medical Sciences (AFRIMS), including the history of vaccine development globally and in Thailand, and an update on the P5 research program in Africa and its relation to vaccine trials in Thailand; attended by the mayor of Pattaya.


    ;

    ;

Uganda

  • Grassroots and district level outreach events for fishing communities and high-risk young women to provide updates on currently available prevention options and the need for continued vaccine research—supported and led by IAVI-UVRI and MRC/UVRI.
  • Two television talk shows, one in English and one in Uganda providing updates on Uganda’s role in the global efforts to develop an HIV vaccine—supported by the Vaccine Interest Group.

United States

  • San Francisco Bay Area meeting with community members and providers to learn about and discuss current HIV vaccine research.

Avac Event

HIVR4P

Sheraton Grand Chicago

HIVR4P is the only global conference that supports cross-fertilization among research on HIV vaccines, microbicides, PrEP, treatment as prevention and other biomedical prevention approaches, while also providing a venue to discuss the research findings, questions and priorities specific to each. The full program is available online here.

Following Along—From Near and Afar

Each day AVAC offered up a selective, whirlwind tour of the day’s session via our Advocates’ Network mailing list. If you’re not already signed up, visit here.

Daily Dispatches

Blog Reaction to R4P

Watch this space. More blogs coming soon.

Social Media, News and Webcasts

We posted to Twitter and Facebook.

And aidsmap was the official online news partner for R4P. Find their updates here.

The conference organizers archived recordings of all sessions. Visit here to see the webcasts.